Literature DB >> 12592800

Deaf and hard of hearing Americans' instant messaging and e-mail use: a national survey.

Frank G Bowe1.   

Abstract

An online survey of 884 deaf and hard of hearing adults asked about their current and past use of communication technologies, notably TTY, telecommunications relay services, e-mail, and instant messaging (IM). Results showed that respondents were using e-mail and IM far more than TTY and relay services. The study participants virtually all had e-mail and IM at home. In fact, about one quarter had a high-speed ("broadband") connection at home. While the vast majority also had and used e-mail at work, just 1 in 3 had IM at his or her place of employment. The findings have several implications. Most important for educators is that strong reading and writing skills are essential if adults who are deaf or hard of hearing are to take advantage of today's communications technologies. Another conclusion is that some workers who are deaf or hard of hearing appear to face discrimination in employment because office policies forbid the use of a highly effective reasonable accommodation, instant messaging.

Entities:  

Mesh:

Year:  2002        PMID: 12592800     DOI: 10.1353/aad.2012.0251

Source DB:  PubMed          Journal:  Am Ann Deaf        ISSN: 0002-726X


  3 in total

1.  Consumer motivations for pursuing genetic testing and their preferences for the provision of genetic services for hearing loss.

Authors:  Kara A Withrow; Sarah Burton; Kathleen S Arnos; Andrea Kalfoglou; Arti Pandya
Journal:  J Genet Couns       Date:  2008-02-05       Impact factor: 2.537

2.  The outcomes of a mobile just-in-time-learning intervention for teaching bioethics in Pakistan.

Authors:  Azra Naseem; Sameer Nizamuddin; Kulsoom Ghias
Journal:  BMC Med Educ       Date:  2022-09-13       Impact factor: 3.263

3.  Internet video telephony allows speech reading by deaf individuals and improves speech perception by cochlear implant users.

Authors:  Georgios Mantokoudis; Claudia Dähler; Patrick Dubach; Martin Kompis; Marco D Caversaccio; Pascal Senn
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.